A malaria vaccine developed by Oxford University and Serum Institute of India (SII) has been recommended for large-scale use by the World Health Organization (WHO). The R21/Matrix-M—only the second malaria jab—has shown up to 75% efficacy.
402 Episodes
23 Nov 2024
16 Aug
5 MINS